Table II.
Relationship between PLT levels and clinicopathological characteristics of lung cancer.
| Item | No. of cases (n) | PLT level (×109/l) | t-test | P-value |
|---|---|---|---|---|
| Age (years) | 3.376 | 0.001 | ||
| ≥60 | 52 | 367.66±112.46 | ||
| <60 | 46 | 198.74±108.53 | ||
| Sex | 1.637 | 0.110 | ||
| Male | 51 | 290.55±149.38 | ||
| Female | 47 | 293.76±138.71 | ||
| Clinical stage | 2.580 | 0.010 | ||
| I | 12 | 120.46±16.46 | ||
| II | 21 | 143.75±18.37 | ||
| III | 28 | 261.74±35.89 | ||
| IV | 37 | 413.92±61.34 | ||
| Pathologic type | 1.432 | 0.303 | ||
| Squamous cell carcinoma | 44 | 321.47±139.73 | ||
| Adenocarcinoma | 33 | 286.83±127.37 | ||
| Small cell carcinoma | 21 | 279.64±141.46 | ||
| Distant metastasis | 2.504 | 0.022 | ||
| No | 62 | 215.78±89.43 | ||
| Yes | 36 | 446.66±91.57 |
PLT, platelet.